Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key Players
Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering.
Research and Markets has published Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides, a 281-page report released in September 2026. The report examines how cell-based assays, long a mainstay of pharmaceutical drug development, are becoming central to biotechnology as post-pandemic research activity accelerates.
Key Facts
A Market Where Technology Is Moving Faster Than Demand
The report's central finding is that new technology now allows cell-based assays to measure almost any aspect of cell function. Genomics and immunology are expanding their role, and technical capability is advancing faster than the market itself. That gap is where the report locates both the opportunities and the pitfalls for suppliers and investors.
Market Drivers
The report identifies five factors driving growth:
It also covers three factors limiting growth: the difficulty of developing cell-based assays, instrument integration, and protocol standardisation. Clinical trial failures and the growing role of infectious disease research are examined as further demand factors.
Technology Development
The report assesses five technology areas expected to shape the next five years: 3D assays, automation, software, primary cells, and signalling and reporter gene technologies.
Recent Industry Developments
The report documents recent deals and launches across the sector, including:
The report provides global market sizing by country, with forecasts by user type (Pharma, Research, Industry/Cosmetic) and by product class (Instrument, Reagent, Services, Software). It includes dedicated guides for executives and marketing staff, and for investment analysts and management consultants. Appendices cover FDA cancer drug approvals, clinical trials started, and share of pharma R&D by country.
Competitive Landscape
The report includes 54 company profiles,
For more information about this report visit https://www.researchandmarkets.com/r/qmez2s
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.